Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Rheumatoid Arthritis: HELP
Dr. Roy Fleischmann
Based on 86 articles published since 2007
||||
Expertise Level
The expertise of Dr. Roy Fleischmann ranks in the
  • Top 0.02%
  • ... of 80,178 published authors worldwide on Rheumatoid Arthritis
  • ... from 2007 through 2018
  • ... based on contributions to 86 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Fleischmann, Roy M   ·   Fleischmann, Roy   ·   Fleischmann, R   ·   Fleischmann, Roy M   ·   Fleischmann, R M
Work Locations
Details
Confirmed:
(June 2014) 
  University of Texas Southwestern   Contact    
2017
  • a Medical Director, Metroplex Clinical Research Center , University of Texas Southwestern Medical Center , Dallas , TX , USA. · Pubmed 28829236
  • University of Texas Southwestern Medical Center at Dallas. · Charité Research Organisation, Berlin, Germany. · Altoona Center for Clinical Research, Duncansville, Pennsylvania. · AbbVie, North Chicago, Illinois. · AbbVie, Worcester, Massachusetts. · Pubmed 28941216
  • Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas. · Regeneron Pharmaceuticals, Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · Rio de Janeiro State University, Rio de Janeiro, Brazil. · Centrum Kliniczno-Badawcze, Elblag, Poland. · Poznań University of Medical Sciences, Poznań, Poland. · Charité University Medicine, Free University, and Humboldt University, Berlin, Germany. · Pubmed 27860410
  • Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX, USA. · Swedish Medical Center and University of Washington School of Medicine, Seattle, WA, USA. · Hospital for Special Surgery, New York, NY, USA. · Pfizer Inc, New York, NY, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Inc, Collegeville, PA, USA. · Pubmed 27734232
2016
  • University of Texas Southwestern Medical Center, Dallas. · Brigham and Women's Hospital, Boston, Massachusetts. · University of Colorado, Denver. · Dinesh Khanna, MD: University of Michigan, Ann Arbor. · Bristol-Myers Squibb, Princeton, New Jersey. · University of California at Los Angeles. · Pubmed 26473625
  • University of California, Los Angeles, California, USA. · Charité-University Medicine Berlin, Berlin, Germany. · Rheumatology Research Unit, Nambour Hospital, Sunshine Coast, Australia Department of Medicine, University of Queensland, Queensland, Australia. · Centro Paulista de Investigação Clinica, São Paulo, Brazil. · Pfizer Inc, Groton, Connecticut, USA. · Pfizer Inc, New York, New York, USA. · Pfizer Inc, Collegeville, Pennsylvania, USA. · Department of Medicine, Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Pubmed 26275429
  • Medical University of Vienna and Hietzing Hospital, Vienna, Austria. Electronic address: · Charité, University Medicine Berlin, Berlin, Germany. · Montpellier University Hospital, Montpellier, France. · University of Alabama at Birmingham, Birmingham, AL, USA. · Monash University, Cabrini Health, Malvern, VIC, Australia. · Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QB, Canada. · Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam, Netherlands. · UCB Pharma, Raleigh, NC, USA. · UCB Pharma, Brussels, Belgium. · Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Pubmed 27863807
  • University of Texas Southwestern Medical Center, Dallas. · Bristol-Myers Squibb, Princeton, New Jersey. · University of Colorado, Denver. · Pubmed 27111089
  • VA Palo Alto Health Care System and Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA. · Department of Rheumatology, University of Colorado, Denver, Colorado, USA. · Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Department of Rheumatology & Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Immunoscience, Bristol-Myers Squibb, Princeton, New Jersey, USA. · Global Biometric Sciences, Bristol-Myers Squibb, Princeton, New Jersey, USA. · Pubmed 26359449
2015
  • Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. · Department of Internal Medicine, University of Texas Southwestern Medical Center, 8144 Walnut Hill Lane, Dallas, TX, 75231, USA. · Karolinska Institute, Solnavägen 1, 171 77, Stockholm, Sweden. · Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK. · NIHR Leeds Musculoskeletal and Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Great George Street, Leeds, LS1 3EX, UK. · Department of Rheumatology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. · Research Laboratory and Academic Unit of Clinical Rheumatology, University of Genova, Viale Benedetto XV, 6, 16132, Genova, Italy. · Department of Rheumatology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. · UCB Pharma, 8010 Arco Corporate Drive, Raleigh, NC, 27617, USA. · UCB Pharma, Allée de la Recherche 60, 1070, Brussels, Belgium. · UCB Pharma, 8010 Arco Corporate Drive, Raleigh, NC, 27617, USA. · Paris-Descartes University, 12 Rue de l'École de Médecine, 75006, Paris, France. · Cochin Hospital, 27 Rue du Faubourg Saint-Jacques, 75014, Paris, France. · Pubmed 26568428
  • From the Unit for Clinical Therapy Research, Inflammatory Diseases, Karolinska Institute, Stockholm, Sweden; Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas; Department of Rheumatology, University of California, Los Angeles Medical Center, Los Angeles, California, USA; Roche Products Ltd., Welwyn Garden City, UK.R.F. van Vollenhoven, MD, Chief of the Unit for Clinical Therapy Research, Inflammatory Disease, Karolinska Institute; R.M. Fleischmann, MD, Clinical Professor of Medicine, Department of Internal Medicine, University of Texas, Southwestern Medical Center; D.E. Furst, MD, Carl M. Pearson Professor of Medicine, Department of Rheumatology, University of California, Los Angeles Medical Center; S. Lacey, MSc, Statistician, Roche Products Ltd.; P.B. Lehane, PhD, Senior Clinical Development Scientist, Roche Products Ltd. · From the Unit for Clinical Therapy Research, Inflammatory Diseases, Karolinska Institute, Stockholm, Sweden; Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas; Department of Rheumatology, University of California, Los Angeles Medical Center, Los Angeles, California, USA; Roche Products Ltd., Welwyn Garden City, UK.R.F. van Vollenhoven, MD, Chief of the Unit for Clinical Therapy Research, Inflammatory Disease, Karolinska Institute; R.M. Fleischmann, MD, Clinical Professor of Medicine, Department of Internal Medicine, University of Texas, Southwestern Medical Center; D.E. Furst, MD, Carl M. Pearson Professor of Medicine, Department of Rheumatology, University of California, Los Angeles Medical Center; S. Lacey, MSc, Statistician, Roche Products Ltd.; P.B. Lehane, PhD, Senior Clinical Development Scientist, Roche Products Ltd. · Pubmed 26276965
  • University of Texas Southwestern Medical Center, Dallas. · Pubmed 25385260
  • Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School and UMass Memorial Medical Center, Worcester, Massachusetts, USA. · Department of Rheumatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Department of Rheumatology, University of Toronto, Toronto, Ontario, Canada. · Janssen Research & Development, LLC, Spring House, Pennsylvania, USA University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Janssen Research & Development, LLC, Spring House, Pennsylvania, USA. · Department of Rheumatology, Rheumazentrum Ruhrgebeit, Herne, Germany. · Division of Rheumatology, Allergy and Immunology, University of California, San Diego, California, USA. · Pubmed 24344160
  • Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Specialty Care, Pfizer Inc, Collegeville, Pennsylvania, USA. · Pubmed 25143522
  • Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany. · Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA. · AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany. · AbbVie Inc, North Chicago, Illinois, USA. · AbbVie, Rungis, France. · University of Texas Southwestern, Dallas, Texas, USA. · Pubmed 24550168
  • University of Texas Southwestern Medical Center at Dallas, Metroplex Clinical Research Center, 8144 Walnut Hill Lane, Suite 800, Dallas, TX 75231, USA. · Pubmed 25385416
  • Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Pubmed 25326219
2014
  • Division of Immunology and Rheumatology, Stanford University Medical Center, Stanford, USA. · Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA. · Department of Medicine, UCLA, Los Angeles, California, USA. · Houston Institute for Clinical Research, Houston, USA. · Division of Rheumatology, University of South Florida Health, Tampa, Florida, USA. · Department of Rheumatology, Southend University Hospital, Westcliff-on-Sea, UK. · UCB Pharma, Raleigh, USA. · William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · UCB Pharma, Slough, UK. · Pubmed 24641941
  • Amsterdam Rheumatology & immunology Center, Academic Medical Center/University of Amsterdam, The Netherlands Department of Rheumatology, Atrium Medical Center Heerlen, The Netherlands. · Division of Rheumatology, Department of Medicine Three, Medical University Vienna & Second Department of Medicine, Hietzing Hospital, Vienna, Austria. · Division of Rheumatology, Immunology and Allergy,
Brigham and Women's Hospital
Harvard Medical School, Boston, USA. · Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. · Rheumatology Department, Paris Descartes University, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, Fance. · Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA. · Division of Rheumatology, Department of Medicine Three, Medical University Vienna, Austria. · Rheumatology, Allergy, Immunology Division, University of California, San Diego, USA. · Department of rheumatology, Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 25114058
  • Department of Medicine, Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, Pfizer Inc., Collegeville, PA, USA and Pfizer Europe, Rome, Italy · Department of Medicine, Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, Pfizer Inc., Collegeville, PA, USA and Pfizer Europe, Rome, Italy. · Pubmed 24907147
  • Division of Rheumatology, Department of Medicine Three, Medical University of Vienna, Vienna, Austria; Second Department of Medicine, Hietzing Hospital, Vienna, Austria. Electronic address: · Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK; NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. · Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Karolinska University Hospital, Stockholm, Sweden. · Institute and Clinic of Rheumatology, First Medical Faculty, Charles University, Prague, Czech Republic. · Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · AbbVie, North Chicago, IL, USA. · AbbVie Deutschland GmbH and Company KG, Ludwigshafen, Germany. · Division of Rheumatology, Allergy and Immunology, University of California San Diego, La Jolla, CA, USA. · Pubmed 24168956
  • Charité-University Medicine Berlin, Berlin, Germany. · Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA. · AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany. · AbbVie Inc., North Chicago, Illinois, USA. · AbbVie, Rungis, France. · University of Texas Southwestern, Dallas, Texas, USA. · Pubmed 24914070
  • Department of Medicine, University of Texas Southwestern Medical Center, Metroplex Clinical Research Center, Dallas, Texas, USA. · Department of Medicine, New York University School of Medicine, NYU Hospital for Joint Diseases, New York, USA. · Pubmed 24894190
2012
  • University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Pubmed 22357358
  • Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX 75231, USA. · Pubmed 21952978
2010
  • University of Texas Southwestern Medical School, Metroplex Clinical Research Center, 8144 Walnut Hill Lane, Suite 800, Dallas, Texas 75231, USA. · Pubmed 20504106
2009
  • University of Texas Southwestern Medical Center, and Metroplex Clinical Research Center, Dallas, TX 75235-5360, USA. · Pubmed 18336874
  • Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX 75231, USA. · Pubmed 19877057
  • University of Texas Southwestern Medical Center, Dallas, 75235, USA. · Pubmed 19015206
2007
  • The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235, USA. · Pubmed 17362051
2016
  • From the Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center, and University of Massachusetts Medical School, Worcester, Massachusetts; Rheumatology, University of Texas Southwestern Medical Center and Metroplex Clinical Research Center, Dallas, Texas; Janssen Research and Development LLC, Spring House; University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Rheumatology, University of Toronto, Toronto, Ontario, Canada; Rheumatology, Rheumazentrum Ruhrgebeit, Herne, Germany. · J. Kay, MD, Division of Rheumatology, and Department of Medicine, UMass Memorial Medical Center, University of Massachusetts Medical School; R. Fleischmann, MD, Rheumatology, University of Texas Southwestern Medical Center, and Metroplex Clinical Research Center; E. Keystone, MD, FRCP(C), Division of Rheumatology, University of Toronto; E.C. Hsia, MD, Janssen Research and Development LLC, and University of Pennsylvania; B. Hsu, MD, PhD, Janssen Research and Development LLC, and University of Pennsylvania; Y. Zhou, PhD, Janssen Research and Development LLC; N. Goldstein, MD, Janssen Research and Development LLC; J. Braun, MD, Rheumatology, Rheumazentrum Ruhrgebeit. · From the Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center, and University of Massachusetts Medical School, Worcester, Massachusetts; Rheumatology, University of Texas Southwestern Medical Center and Metroplex Clinical Research Center, Dallas, Texas; Janssen Research and Development LLC, Spring House; University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Rheumatology, University of Toronto, Toronto, Ontario, Canada; Rheumatology, Rheumazentrum Ruhrgebeit, Herne, Germany. · J. Kay, MD, Division of Rheumatology, and Department of Medicine, UMass Memorial Medical Center, University of Massachusetts Medical School; R. Fleischmann, MD, Rheumatology, University of Texas Southwestern Medical Center, and Metroplex Clinical Research Center; E. Keystone, MD, FRCP(C), Division of Rheumatology, University of Toronto; E.C. Hsia, MD, Janssen Research and Development LLC, and University of Pennsylvania; B. Hsu, MD, PhD, Janssen Research and Development LLC, and University of Pennsylvania; Y. Zhou, PhD, Janssen Research and Development LLC; N. Goldstein, MD, Janssen Research and Development LLC; J. Braun, MD, Rheumatology, Rheumazentrum Ruhrgebeit. · Pubmed 27803138
2008
  • The University of Texas Southwestern Medical Center, Office of Continuing Education, 5323 Harry Hines Blvd., Dallas, TX 75390-9059, USA. · Pubmed 19193621
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 86 total) written by Dr. Roy Fleischmann about Rheumatoid Arthritis:

  • A review of tofacitinib efficacy in rheumatoid arthritis patients who have had an inadequate response or intolerance to methotrexate. 2017
  • Safety, Tolerability, and Pharmacodynamics of ABT-122, a Tumor Necrosis Factor- and Interleukin-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With Rheumatoid Arthritis. 2017
  • Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors. 2017
  • Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group. 2017
  • Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment. 2017
  • Disease-Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid Arthritis. 2017
  • Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studies. 2016
  • Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis. 2016
  • Pharmacokinetics and safety of single doses of tabalumab in subjects with rheumatoid arthritis or systemic lupus erythematosus. 2016
  • Patient-Reported Outcomes From a Two-Year Head-to-Head Comparison of Subcutaneous Abatacept and Adalimumab for Rheumatoid Arthritis. 2016
Show List of Full Article Records
Google Searches

Learn more about Dr. Roy Fleischmann using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Southwestern
Affiliation Timeline What is this?
University of Texas Southwestern
2017
  • a Medical Director, Metroplex Clinical Research Center , University of Texas Southwestern Medical Center , Dallas , TX , USA. · Pubmed 28829236
  • University of Texas Southwestern Medical Center at Dallas. · Charité Research Organisation, Berlin, Germany. · Altoona Center for Clinical Research, Duncansville, Pennsylvania. · AbbVie, North Chicago, Illinois. · AbbVie, Worcester, Massachusetts. · Pubmed 28941216
  • Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas. · Regeneron Pharmaceuticals, Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · Rio de Janeiro State University, Rio de Janeiro, Brazil. · Centrum Kliniczno-Badawcze, Elblag, Poland. · Poznań University of Medical Sciences, Poznań, Poland. · Charité University Medicine, Free University, and Humboldt University, Berlin, Germany. · Pubmed 27860410
  • Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX, USA. · Swedish Medical Center and University of Washington School of Medicine, Seattle, WA, USA. · Hospital for Special Surgery, New York, NY, USA. · Pfizer Inc, New York, NY, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Inc, Collegeville, PA, USA. · Pubmed 27734232
2016
  • University of Texas Southwestern Medical Center, Dallas. · Brigham and Women's Hospital, Boston, Massachusetts. · University of Colorado, Denver. · Dinesh Khanna, MD: University of Michigan, Ann Arbor. · Bristol-Myers Squibb, Princeton, New Jersey. · University of California at Los Angeles. · Pubmed 26473625
  • University of California, Los Angeles, California, USA. · Charité-University Medicine Berlin, Berlin, Germany. · Rheumatology Research Unit, Nambour Hospital, Sunshine Coast, Australia Department of Medicine, University of Queensland, Queensland, Australia. · Centro Paulista de Investigação Clinica, São Paulo, Brazil. · Pfizer Inc, Groton, Connecticut, USA. · Pfizer Inc, New York, New York, USA. · Pfizer Inc, Collegeville, Pennsylvania, USA. · Department of Medicine, Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Pubmed 26275429
  • Medical University of Vienna and Hietzing Hospital, Vienna, Austria. Electronic address: · Charité, University Medicine Berlin, Berlin, Germany. · Montpellier University Hospital, Montpellier, France. · University of Alabama at Birmingham, Birmingham, AL, USA. · Monash University, Cabrini Health, Malvern, VIC, Australia. · Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QB, Canada. · Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam, Netherlands. · UCB Pharma, Raleigh, NC, USA. · UCB Pharma, Brussels, Belgium. · Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Pubmed 27863807
  • University of Texas Southwestern Medical Center, Dallas. · Bristol-Myers Squibb, Princeton, New Jersey. · University of Colorado, Denver. · Pubmed 27111089
  • VA Palo Alto Health Care System and Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA. · Department of Rheumatology, University of Colorado, Denver, Colorado, USA. · Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Department of Rheumatology & Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Immunoscience, Bristol-Myers Squibb, Princeton, New Jersey, USA. · Global Biometric Sciences, Bristol-Myers Squibb, Princeton, New Jersey, USA. · Pubmed 26359449
2015
  • Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. · Department of Internal Medicine, University of Texas Southwestern Medical Center, 8144 Walnut Hill Lane, Dallas, TX, 75231, USA. · Karolinska Institute, Solnavägen 1, 171 77, Stockholm, Sweden. · Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK. · NIHR Leeds Musculoskeletal and Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Great George Street, Leeds, LS1 3EX, UK. · Department of Rheumatology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. · Research Laboratory and Academic Unit of Clinical Rheumatology, University of Genova, Viale Benedetto XV, 6, 16132, Genova, Italy. · Department of Rheumatology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. · UCB Pharma, 8010 Arco Corporate Drive, Raleigh, NC, 27617, USA. · UCB Pharma, Allée de la Recherche 60, 1070, Brussels, Belgium. · UCB Pharma, 8010 Arco Corporate Drive, Raleigh, NC, 27617, USA. · Paris-Descartes University, 12 Rue de l'École de Médecine, 75006, Paris, France. · Cochin Hospital, 27 Rue du Faubourg Saint-Jacques, 75014, Paris, France. · Pubmed 26568428
  • From the Unit for Clinical Therapy Research, Inflammatory Diseases, Karolinska Institute, Stockholm, Sweden; Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas; Department of Rheumatology, University of California, Los Angeles Medical Center, Los Angeles, California, USA; Roche Products Ltd., Welwyn Garden City, UK.R.F. van Vollenhoven, MD, Chief of the Unit for Clinical Therapy Research, Inflammatory Disease, Karolinska Institute; R.M. Fleischmann, MD, Clinical Professor of Medicine, Department of Internal Medicine, University of Texas, Southwestern Medical Center; D.E. Furst, MD, Carl M. Pearson Professor of Medicine, Department of Rheumatology, University of California, Los Angeles Medical Center; S. Lacey, MSc, Statistician, Roche Products Ltd.; P.B. Lehane, PhD, Senior Clinical Development Scientist, Roche Products Ltd. · From the Unit for Clinical Therapy Research, Inflammatory Diseases, Karolinska Institute, Stockholm, Sweden; Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas; Department of Rheumatology, University of California, Los Angeles Medical Center, Los Angeles, California, USA; Roche Products Ltd., Welwyn Garden City, UK.R.F. van Vollenhoven, MD, Chief of the Unit for Clinical Therapy Research, Inflammatory Disease, Karolinska Institute; R.M. Fleischmann, MD, Clinical Professor of Medicine, Department of Internal Medicine, University of Texas, Southwestern Medical Center; D.E. Furst, MD, Carl M. Pearson Professor of Medicine, Department of Rheumatology, University of California, Los Angeles Medical Center; S. Lacey, MSc, Statistician, Roche Products Ltd.; P.B. Lehane, PhD, Senior Clinical Development Scientist, Roche Products Ltd. · Pubmed 26276965
  • University of Texas Southwestern Medical Center, Dallas. · Pubmed 25385260
  • Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School and UMass Memorial Medical Center, Worcester, Massachusetts, USA. · Department of Rheumatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Department of Rheumatology, University of Toronto, Toronto, Ontario, Canada. · Janssen Research & Development, LLC, Spring House, Pennsylvania, USA University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Janssen Research & Development, LLC, Spring House, Pennsylvania, USA. · Department of Rheumatology, Rheumazentrum Ruhrgebeit, Herne, Germany. · Division of Rheumatology, Allergy and Immunology, University of California, San Diego, California, USA. · Pubmed 24344160
  • Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Specialty Care, Pfizer Inc, Collegeville, Pennsylvania, USA. · Pubmed 25143522
  • Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany. · Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA. · AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany. · AbbVie Inc, North Chicago, Illinois, USA. · AbbVie, Rungis, France. · University of Texas Southwestern, Dallas, Texas, USA. · Pubmed 24550168
  • University of Texas Southwestern Medical Center at Dallas, Metroplex Clinical Research Center, 8144 Walnut Hill Lane, Suite 800, Dallas, TX 75231, USA. · Pubmed 25385416
  • Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Pubmed 25326219
2014
  • Division of Immunology and Rheumatology, Stanford University Medical Center, Stanford, USA. · Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA. · Department of Medicine, UCLA, Los Angeles, California, USA. · Houston Institute for Clinical Research, Houston, USA. · Division of Rheumatology, University of South Florida Health, Tampa, Florida, USA. · Department of Rheumatology, Southend University Hospital, Westcliff-on-Sea, UK. · UCB Pharma, Raleigh, USA. · William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · UCB Pharma, Slough, UK. · Pubmed 24641941
  • Amsterdam Rheumatology & immunology Center, Academic Medical Center/University of Amsterdam, The Netherlands Department of Rheumatology, Atrium Medical Center Heerlen, The Netherlands. · Division of Rheumatology, Department of Medicine Three, Medical University Vienna & Second Department of Medicine, Hietzing Hospital, Vienna, Austria. · Division of Rheumatology, Immunology and Allergy,
Brigham and Women's Hospital
Harvard Medical School, Boston, USA. · Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. · Rheumatology Department, Paris Descartes University, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, Fance. · Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA. · Division of Rheumatology, Department of Medicine Three, Medical University Vienna, Austria. · Rheumatology, Allergy, Immunology Division, University of California, San Diego, USA. · Department of rheumatology, Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 25114058
  • Department of Medicine, Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, Pfizer Inc., Collegeville, PA, USA and Pfizer Europe, Rome, Italy · Department of Medicine, Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, Pfizer Inc., Collegeville, PA, USA and Pfizer Europe, Rome, Italy. · Pubmed 24907147
  • Division of Rheumatology, Department of Medicine Three, Medical University of Vienna, Vienna, Austria; Second Department of Medicine, Hietzing Hospital, Vienna, Austria. Electronic address: · Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK; NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. · Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Karolinska University Hospital, Stockholm, Sweden. · Institute and Clinic of Rheumatology, First Medical Faculty, Charles University, Prague, Czech Republic. · Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · AbbVie, North Chicago, IL, USA. · AbbVie Deutschland GmbH and Company KG, Ludwigshafen, Germany. · Division of Rheumatology, Allergy and Immunology, University of California San Diego, La Jolla, CA, USA. · Pubmed 24168956
  • Charité-University Medicine Berlin, Berlin, Germany. · Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA. · AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany. · AbbVie Inc., North Chicago, Illinois, USA. · AbbVie, Rungis, France. · University of Texas Southwestern, Dallas, Texas, USA. · Pubmed 24914070
  • Department of Medicine, University of Texas Southwestern Medical Center, Metroplex Clinical Research Center, Dallas, Texas, USA. · Department of Medicine, New York University School of Medicine, NYU Hospital for Joint Diseases, New York, USA. · Pubmed 24894190
2012
  • University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Pubmed 22357358
  • Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX 75231, USA. · Pubmed 21952978
2010
  • University of Texas Southwestern Medical School, Metroplex Clinical Research Center, 8144 Walnut Hill Lane, Suite 800, Dallas, Texas 75231, USA. · Pubmed 20504106
2009
  • University of Texas Southwestern Medical Center, and Metroplex Clinical Research Center, Dallas, TX 75235-5360, USA. · Pubmed 18336874
  • Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX 75231, USA. · Pubmed 19877057
  • University of Texas Southwestern Medical Center, Dallas, 75235, USA. · Pubmed 19015206
2007
  • The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235, USA. · Pubmed 17362051
2016
  • From the Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center, and University of Massachusetts Medical School, Worcester, Massachusetts; Rheumatology, University of Texas Southwestern Medical Center and Metroplex Clinical Research Center, Dallas, Texas; Janssen Research and Development LLC, Spring House; University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Rheumatology, University of Toronto, Toronto, Ontario, Canada; Rheumatology, Rheumazentrum Ruhrgebeit, Herne, Germany. · J. Kay, MD, Division of Rheumatology, and Department of Medicine, UMass Memorial Medical Center, University of Massachusetts Medical School; R. Fleischmann, MD, Rheumatology, University of Texas Southwestern Medical Center, and Metroplex Clinical Research Center; E. Keystone, MD, FRCP(C), Division of Rheumatology, University of Toronto; E.C. Hsia, MD, Janssen Research and Development LLC, and University of Pennsylvania; B. Hsu, MD, PhD, Janssen Research and Development LLC, and University of Pennsylvania; Y. Zhou, PhD, Janssen Research and Development LLC; N. Goldstein, MD, Janssen Research and Development LLC; J. Braun, MD, Rheumatology, Rheumazentrum Ruhrgebeit. · From the Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center, and University of Massachusetts Medical School, Worcester, Massachusetts; Rheumatology, University of Texas Southwestern Medical Center and Metroplex Clinical Research Center, Dallas, Texas; Janssen Research and Development LLC, Spring House; University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Rheumatology, University of Toronto, Toronto, Ontario, Canada; Rheumatology, Rheumazentrum Ruhrgebeit, Herne, Germany. · J. Kay, MD, Division of Rheumatology, and Department of Medicine, UMass Memorial Medical Center, University of Massachusetts Medical School; R. Fleischmann, MD, Rheumatology, University of Texas Southwestern Medical Center, and Metroplex Clinical Research Center; E. Keystone, MD, FRCP(C), Division of Rheumatology, University of Toronto; E.C. Hsia, MD, Janssen Research and Development LLC, and University of Pennsylvania; B. Hsu, MD, PhD, Janssen Research and Development LLC, and University of Pennsylvania; Y. Zhou, PhD, Janssen Research and Development LLC; N. Goldstein, MD, Janssen Research and Development LLC; J. Braun, MD, Rheumatology, Rheumazentrum Ruhrgebeit. · Pubmed 27803138
2008
  • The University of Texas Southwestern Medical Center, Office of Continuing Education, 5323 Harry Hines Blvd., Dallas, TX 75390-9059, USA. · Pubmed 19193621
Metroplex Clinical Research Center
2017
  • a Medical Director, Metroplex Clinical Research Center , University of Texas Southwestern Medical Center , Dallas , TX , USA. · Pubmed 28829236
  • Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas. · Regeneron Pharmaceuticals, Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · Rio de Janeiro State University, Rio de Janeiro, Brazil. · Centrum Kliniczno-Badawcze, Elblag, Poland. · Poznań University of Medical Sciences, Poznań, Poland. · Charité University Medicine, Free University, and Humboldt University, Berlin, Germany. · Pubmed 27860410
  • Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX, USA. · Swedish Medical Center and University of Washington School of Medicine, Seattle, WA, USA. · Hospital for Special Surgery, New York, NY, USA. · Pfizer Inc, New York, NY, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Inc, Collegeville, PA, USA. · Pubmed 27734232
  • Metroplex Clinical Research Center, Dallas, Texas. · University of Colorado, Denver. · Leiden University Medical Center, Leiden, The Netherlands, and Imaging Rheumatology BV, Meerssen, The Netherlands. · Unidad de Investigacion en Enfermedades Cronico-Degenerativas, Guadalajara, Mexico. · Centro Medico Privado de Reumatologia, Tucuman, Argentina. · Scientific Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, Russia. · Centro Paulista de Investigação Clinica, São Paulo, Brazil. · Eli Lilly and Company, Indianapolis, Indiana. · Keio University School of Medicine, Tokyo, Japan. · Pubmed 27723271
  • Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. · Sanofi Genzyme, 55 Corporate Drive, Bridgewater, NJ, 08807, USA. · Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA. · Metroplex Clinical Research Center, 8144 Walnut Hill Lane, No. 810, Dallas, 75231, TX, USA. · Arensia Exploratory Medicine GmbH, Moskauer Str. 25, 40227, Düsseldorf, Germany. · Altoona Center for Clinical Research, 175 Meadowbrook Lane, Duncansville, PA, 16635, USA. · Pubmed 27722854
2016
  • Metroplex Clinical Research Center, Dallas, Texas, USA. · Center for Rheumatology, Albany Medical College, Albany, New York, USA. · First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. · Pfizer Inc., Groton, Connecticut, USA. · Pfizer Inc., New York, New York, USA. · Mount Sinai Hospital, Toronto, Ontario, Canada. · Pubmed 27451980
  • Private residence, CA, USA. · Department of Medicine, Karolinska Institute, Stockholm, Sweden. · Department of Internal Medicine, Seoul National University, Seoul, Republic of Korea. · Rheumatology Department, Metroplex Clinical Research Center, Dallas, TX. · Medicines Development Group, Pfizer Inc, Groton, CT and. · Medicines Development Group, Pfizer Inc, New York, NY, USA. · Medicines Development Group, Pfizer Inc, Groton, CT and · Pubmed 26929445
  • Eli Lilly and Company, Indianapolis, Indiana. · Metroplex Clinical Research Center, Dallas, Texas. · Pinnacle Research Group, Anniston, Alabama, USA. · Eli Lilly and Company, Windlesham, UK. · Pubmed 26648084
  • University of California, Los Angeles, California, USA. · Charité-University Medicine Berlin, Berlin, Germany. · Rheumatology Research Unit, Nambour Hospital, Sunshine Coast, Australia Department of Medicine, University of Queensland, Queensland, Australia. · Centro Paulista de Investigação Clinica, São Paulo, Brazil. · Pfizer Inc, Groton, Connecticut, USA. · Pfizer Inc, New York, New York, USA. · Pfizer Inc, Collegeville, Pennsylvania, USA. · Department of Medicine, Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Pubmed 26275429
  • Medical University of Vienna and Hietzing Hospital, Vienna, Austria. Electronic address: · Charité, University Medicine Berlin, Berlin, Germany. · Montpellier University Hospital, Montpellier, France. · University of Alabama at Birmingham, Birmingham, AL, USA. · Monash University, Cabrini Health, Malvern, VIC, Australia. · Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QB, Canada. · Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam, Netherlands. · UCB Pharma, Raleigh, NC, USA. · UCB Pharma, Brussels, Belgium. · Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Pubmed 27863807
  • Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Groton, CT, USA. · Metroplex Clinical Research Center, Dallas, TX, USA. · University of Genoa, Italy. · Stanford University, Stanford, CA, USA. · Hospital Clinico Universitario, Santiago de Compostela, Spain. · Albany Medical College, Albany, NY, USA. · Seoul National University College of Medicine, Seoul, Republic of Korea. · Instituto Nacional de Ciencias Médicas y Nutrición-Salvador Zubirán, Mexico City, Mexico. · Pubmed 27156561
  • Albany Medical College, Albany, New York, USA. · Hospital Marques de Valdecilla, IDIVAL, Santander, Spain. · Panorama Medical Center, Cape Town, South Africa. · Rheumatology and Internal Diseases Clinic, Pomeranian Medical University, Szczecin, Poland. · Hospital General de México and Universidad Nacional Autónoma de México, Mexico City, Mexico. · Roche Products Ltd., Welwyn Garden City, UK. · Metroplex Clinical Research Center, Dallas, Texas, USA. · Pubmed 27087059
  • Metroplex Clinical Research Center, Dallas, TX, USA. · Pfizer Inc., Collegeville, PA, USA. · Pfizer Inc., Groton, CT, USA. · Pfizer Inc., New York, NY, USA. · Metroplex Clinical Research Center, Dallas, TX, USA. · Pubmed 26575982
2015
  • Biopharmaceutical Consultant, Portola Valley, CA, USA. · Stanford University, Palo Alto, CA, USA. · Center for Rheumatology, Albany Medical College, Albany, NY, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Metroplex Clinical Research Center, Dallas, TX, USA. · Pubmed 26530039
  • Stanford University Medical Center, Palo Alto, California. · Metroplex Clinical Research Center, Dallas, Texas. · Altoona Center for Clinical Research, Duncansville, Pennsylvania. · Rheumatology and Osteoporosis Outpatient Clinic, Warsaw, Poland. · Sanofi, Prague, Czech Republic. · Sanofi, Bridgewater, New Jersey. · Regeneron Pharmaceuticals, Tarrytown, New York. · Leiden University Medical Centre, Leiden, The Netherlands. · Pubmed 25733246
  • St. Joseph's Health Care, University of Western Ontario, London, ON, Canada. · Divisions of Rheumatology and Allergy, Johns Hopkins University, Baltimore, MD, USA. · Metroplex Clinical Research Center, University of Texas, Dallas, TX, USA. · Département de Rhumatologie, Paris Descartes University, 12 Rue de l'École de Médecine, 75006, Paris, France. · Department of Medicine, Rheumatology, Immunology, Brigham and Women's Hospital, Boston, MA, USA. · Klinik für Rheumatologie, Schön Klinik Hamburg Eilbek, Hamburg, Germany. · UCB Pharma, Raleigh, NC, USA. · UCB Pharma, Brussels, Belgium. · Department of Medicine, Rheumatology, Immunology, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 26614481
  • Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Specialty Care, Pfizer Inc, Collegeville, Pennsylvania, USA. · Pubmed 25143522
  • University of Texas Southwestern Medical Center at Dallas, Metroplex Clinical Research Center, 8144 Walnut Hill Lane, Suite 800, Dallas, TX 75231, USA. · Pubmed 25385416
2014
  • Department of Medicine, University of Texas Southwestern Medical Center, Metroplex Clinical Research Center, Dallas, Texas, USA. · Department of Medicine, New York University School of Medicine, NYU Hospital for Joint Diseases, New York, USA. · Pubmed 24894190
2012
  • Metroplex Clinical Research Center, Dallas, TX 75231, USA. · Pubmed 22873530
  • Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX 75231, USA. · Pubmed 21952978
2010
  • University of Texas Southwestern Medical School, Metroplex Clinical Research Center, 8144 Walnut Hill Lane, Suite 800, Dallas, Texas 75231, USA. · Pubmed 20504106
  • Metroplex Clinical Research Center, 8144 Walnut Hill Lane, Dallas, Texas 75231, USA. · Pubmed 20230188
2009
  • University of Texas Southwestern Medical Center, and Metroplex Clinical Research Center, Dallas, TX 75235-5360, USA. · Pubmed 18336874
  • Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX 75231, USA. · Pubmed 19877057
2016
  • From the Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center, and University of Massachusetts Medical School, Worcester, Massachusetts; Rheumatology, University of Texas Southwestern Medical Center and Metroplex Clinical Research Center, Dallas, Texas; Janssen Research and Development LLC, Spring House; University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Rheumatology, University of Toronto, Toronto, Ontario, Canada; Rheumatology, Rheumazentrum Ruhrgebeit, Herne, Germany. · J. Kay, MD, Division of Rheumatology, and Department of Medicine, UMass Memorial Medical Center, University of Massachusetts Medical School; R. Fleischmann, MD, Rheumatology, University of Texas Southwestern Medical Center, and Metroplex Clinical Research Center; E. Keystone, MD, FRCP(C), Division of Rheumatology, University of Toronto; E.C. Hsia, MD, Janssen Research and Development LLC, and University of Pennsylvania; B. Hsu, MD, PhD, Janssen Research and Development LLC, and University of Pennsylvania; Y. Zhou, PhD, Janssen Research and Development LLC; N. Goldstein, MD, Janssen Research and Development LLC; J. Braun, MD, Rheumatology, Rheumazentrum Ruhrgebeit. · From the Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center, and University of Massachusetts Medical School, Worcester, Massachusetts; Rheumatology, University of Texas Southwestern Medical Center and Metroplex Clinical Research Center, Dallas, Texas; Janssen Research and Development LLC, Spring House; University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Rheumatology, University of Toronto, Toronto, Ontario, Canada; Rheumatology, Rheumazentrum Ruhrgebeit, Herne, Germany. · J. Kay, MD, Division of Rheumatology, and Department of Medicine, UMass Memorial Medical Center, University of Massachusetts Medical School; R. Fleischmann, MD, Rheumatology, University of Texas Southwestern Medical Center, and Metroplex Clinical Research Center; E. Keystone, MD, FRCP(C), Division of Rheumatology, University of Toronto; E.C. Hsia, MD, Janssen Research and Development LLC, and University of Pennsylvania; B. Hsu, MD, PhD, Janssen Research and Development LLC, and University of Pennsylvania; Y. Zhou, PhD, Janssen Research and Development LLC; N. Goldstein, MD, Janssen Research and Development LLC; J. Braun, MD, Rheumatology, Rheumazentrum Ruhrgebeit. · Pubmed 27803138
2014
  • From Seoul National University College of Medicine, Seoul, South Korea (E.B.L.); Metroplex Clinical Research Center, Dallas (R.F.); Cabrini Health and Monash University, Melbourne, VIC, Australia (S.H.); Pfizer, Groton, CT (B.W., J.D.B., D.G., S.K., G.V.W., C.Z., S.H.Z.); Pfizer, New York (T.K.); and Karolinska Institute, Stockholm (R.F.V.). · Pubmed 24941177
2010
Miscellaneous institutions in Dallas
2016
  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Hospitals NHS Trust, Leeds, UK. · University of Texas and Southwest Medical Center, Dallas, Texas. · Instituto Reumatológico Strusberg, Córdoba, Argentina. · Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, and Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · University of Queensland, Queensland, Australia. · University of the Philippines General Hospital, Manila, Philippines. · Arthritis Center of Nebraska, Lincoln. · Inha University Hospital, Incheon, South Korea. · Sanatorio Parque, Santa Fe, Argentina. · Janssen Global Services, LLC, Malvern, Pennsylvania. · Janssen Research & Development, Spring House, Pennsylvania. · Janssen Research & Development, Spring House, Pennsylvania, and University of Pennsylvania School of Medicine, Philadelphia. · Pubmed 26474452
2014
  • Metroplex Center for Clinical Research , Dallas, TX , USA. · Pubmed 25050591
UCLA
2015
  • From the Unit for Clinical Therapy Research, Inflammatory Diseases, Karolinska Institute, Stockholm, Sweden; Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas; Department of Rheumatology, University of California, Los Angeles Medical Center, Los Angeles, California, USA; Roche Products Ltd., Welwyn Garden City, UK.R.F. van Vollenhoven, MD, Chief of the Unit for Clinical Therapy Research, Inflammatory Disease, Karolinska Institute; R.M. Fleischmann, MD, Clinical Professor of Medicine, Department of Internal Medicine, University of Texas, Southwestern Medical Center; D.E. Furst, MD, Carl M. Pearson Professor of Medicine, Department of Rheumatology, University of California, Los Angeles Medical Center; S. Lacey, MSc, Statistician, Roche Products Ltd.; P.B. Lehane, PhD, Senior Clinical Development Scientist, Roche Products Ltd. · From the Unit for Clinical Therapy Research, Inflammatory Diseases, Karolinska Institute, Stockholm, Sweden; Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas; Department of Rheumatology, University of California, Los Angeles Medical Center, Los Angeles, California, USA; Roche Products Ltd., Welwyn Garden City, UK.R.F. van Vollenhoven, MD, Chief of the Unit for Clinical Therapy Research, Inflammatory Disease, Karolinska Institute; R.M. Fleischmann, MD, Clinical Professor of Medicine, Department of Internal Medicine, University of Texas, Southwestern Medical Center; D.E. Furst, MD, Carl M. Pearson Professor of Medicine, Department of Rheumatology, University of California, Los Angeles Medical Center; S. Lacey, MSc, Statistician, Roche Products Ltd.; P.B. Lehane, PhD, Senior Clinical Development Scientist, Roche Products Ltd. · Pubmed 26276965
2015
2012
  • Rheumatology Department, David Geffen School of Medicine, UCLA - RM 32-59, 1000 Veteran Avenue, Los Angeles, California 90025, USA. · Pubmed 22460137
2007
  • David Geffen School of Medicine, UCLA - RM 32-59, 1000 Veteran Avenue, Los Angeles, CA 90025, USA. · Pubmed 17934088
Karolinska Institutions
2015
  • From the Unit for Clinical Therapy Research, Inflammatory Diseases, Karolinska Institute, Stockholm, Sweden; Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas; Department of Rheumatology, University of California, Los Angeles Medical Center, Los Angeles, California, USA; Roche Products Ltd., Welwyn Garden City, UK.R.F. van Vollenhoven, MD, Chief of the Unit for Clinical Therapy Research, Inflammatory Disease, Karolinska Institute; R.M. Fleischmann, MD, Clinical Professor of Medicine, Department of Internal Medicine, University of Texas, Southwestern Medical Center; D.E. Furst, MD, Carl M. Pearson Professor of Medicine, Department of Rheumatology, University of California, Los Angeles Medical Center; S. Lacey, MSc, Statistician, Roche Products Ltd.; P.B. Lehane, PhD, Senior Clinical Development Scientist, Roche Products Ltd. · From the Unit for Clinical Therapy Research, Inflammatory Diseases, Karolinska Institute, Stockholm, Sweden; Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas; Department of Rheumatology, University of California, Los Angeles Medical Center, Los Angeles, California, USA; Roche Products Ltd., Welwyn Garden City, UK.R.F. van Vollenhoven, MD, Chief of the Unit for Clinical Therapy Research, Inflammatory Disease, Karolinska Institute; R.M. Fleischmann, MD, Clinical Professor of Medicine, Department of Internal Medicine, University of Texas, Southwestern Medical Center; D.E. Furst, MD, Carl M. Pearson Professor of Medicine, Department of Rheumatology, University of California, Los Angeles Medical Center; S. Lacey, MSc, Statistician, Roche Products Ltd.; P.B. Lehane, PhD, Senior Clinical Development Scientist, Roche Products Ltd. · Pubmed 26276965
2014
  • From Seoul National University College of Medicine, Seoul, South Korea (E.B.L.); Metroplex Clinical Research Center, Dallas (R.F.); Cabrini Health and Monash University, Melbourne, VIC, Australia (S.H.); Pfizer, Groton, CT (B.W., J.D.B., D.G., S.K., G.V.W., C.Z., S.H.Z.); Pfizer, New York (T.K.); and Karolinska Institute, Stockholm (R.F.V.). · Pubmed 24941177
2013
  • Unit for Clinical Therapy Research, The Karolinska Institute, Stockholm, Sweden. · Pubmed 23136242
2012
2010
Leiden University
2014
  • Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands. · Division of Rheumatology, Department of Medicine, University of Texas Southwestern Medical Center and Metroplex Clinical Research Center, Dallas, Texas, USA. · Department of Research and Development, Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA. · Department of Research and Development, Sanofi, Bridgewater, New Jersey, USA. · Department of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California, USA. · Pubmed 24297381
2013
  • Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 23348607
Panorama Medical Center
2013
  • Metroplex Clinic Research Center, Dallas, Texas, USA; Panorama Medical Center, Cape Town, South Africa. · Pubmed 23322466
20 Other Locations Show
Yearly article counts 0613121211984524
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.